SIGLEC15 Antikörper (AA 22-319) (HRP)
Kurzübersicht für SIGLEC15 Antikörper (AA 22-319) (HRP) (ABIN8037182)
Target
Alle SIGLEC15 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 22-319
-
Verwendungszweck
- Anti-SIGLEC15 Antibody HRP Conjugated
-
Kreuzreaktivität (Details)
- No cross-reactivity with other proteins
-
Aufreinigung
- Immunogen affinity purified.
-
Immunogen
- E.coli-derived human SIGLEC15 recombinant protein (Position: R22-R319).
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Western blot, Optimal dilutions should be determined by end users. Immunohistochemistry (Paraffin-embedded Section), Optimal dilutions should be determined by end users. ELISA, Optimal dilutions should be determined by end users.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- Each vial contains 50 % glycerol, 0.9 % NaCl, 0.2 % Na2HPO4.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- At -20°C for one year from date of receipt. Avoid repeated freezing and thawing.
-
Haltbarkeit
- 12 months
-
-
- SIGLEC15 (Sialic Acid Binding Ig-Like Lectin 15 (SIGLEC15))
-
Andere Bezeichnung
- SIGLEC15
-
Hintergrund
-
Background: Predicted to be involved in regulation of actin cytoskeleton organization, regulation of bone resorption, and regulation of osteoclast development. Predicted to be located in membrane. Predicted to be part of protein-containing complex. Predicted to be active in plasma membrane.
Gene Full Name: sialic acid binding Ig like lectin 15
-
Gen-ID
- 284266
-
UniProt
- Q6ZMC9
Target
-